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How autoreceptors contribute to maintaining a sta-
ble output of rhythmically active neuronal circuits is
poorly understood. Here, we examine this issue in a
dopamine population, spontaneously oscillating hy-
pothalamic rat (TIDA) neurons, that underlie neuro-
endocrine control of reproduction and neuroleptic
side effects. Activation of dopamine receptors of
the type 2 family (D2Rs) at the cell-body level
slowed TIDA oscillations through two mechanisms.
First, they prolonged the depolarizing phase
through a combination of presynaptic increases in
inhibition and postsynaptic hyperpolarization. Sec-
ond, they extended the discharge phase through
presynaptic attenuation of calcium currents and
decreased synaptic inhibition. Dopamine reuptake
blockade similarly reconfigured the oscillation,
indicating that ambient somatodendritic transmitter
concentration determines electrical behavior. In the
absence of D2R feedback, however, discharge was
abolished by depolarization block. These results
indicate the existence of an ultra-short feedback
loop whereby neuroendocrine dopamine neurons
tune network behavior to echoes of their own activ-
ity, reflected in ambient somatodendritic dopamine,
and also suggest a mechanism for antipsychotic
side effects.INTRODUCTION
Dopamine neurons play a pivotal role in several brain functions,
including cognition, reward, and motor output (Jentsch et al.,
1997; Servan-Schreiber et al., 1998; Reeves et al., 2005; Katz,
1979; Lippa et al., 1973; Graeff, 1966; Ande´n and Stro¨mbom,
1974; Westermann and Staib, 1976). Changes in dopamine
activity have been implicated in, e.g., schizophrenia, addiction,
and Parkinson disease (Stevens et al., 1974; Seeman, 2013;
Compton et al., 1996; Ungless et al., 2010; So¨dersten et al.,
2014; Chase et al., 1974). A physiologically appropriate dopa-
mine output depends, to a great extent, on homeostatic me-
chanisms. These mechanisms are only partly understood butThis is an open access article under the CC BY-Nincludes immediate feedback through autoreceptors (Cragg
and Greenfield, 1997).
Dopamine is also an important signaling molecule in the hypo-
thalamus, where it inhibits prolactin release from the anterior
pituitary (Freeman et al., 2000). The main source of neuroendo-
crine dopamine is the tuberoinfundibular dopamine (TIDA) neu-
rons, located in the dorsomedial hypothalamic arcuate nucleus
(dmArc). TIDA neurons release dopamine into the portal capil-
laries at the median eminence (ME) for transport to the anterior
pituitary gland (Lyons and Broberger, 2014). Patterned dopami-
nergic inhibition within the lactotrophic axis is essential for suc-
cessful reproduction, as evidenced by the impaired fertility and
other sexual side effects associated with the hyperprolactinae-
mia commonly seen in patients treated with antipsychotics
with dopamine antagonist properties (Holt and Peveler, 2011).
The pituitary consequences of TIDA neuron activation are well
established (Fuxe, 1963). However, the actions of dopamine on
TIDA neurons have been the subject of only a few studies and
remain poorly understood. Biochemical studies have indicated
that TIDA neurons may be under inhibitory influence by dopa-
mine receptors of the type 2 family (D2R) (Berry and Gudelsky,
1991; Lin et al., 2000; Liang et al., 2014), but other investigators
have found no effect (Demarest and Moore, 1979a; Timmerman
et al., 1995) or even disinhibition via D2R (Durham et al., 1996).
How autoreceptors affect TIDA membrane properties and
network activity has not been studied. In the ventral tegmental
area (VTA) and the substantia nigra (SN) of the midbrain, where
this issue has been studied in more depth, autoinhibition ap-
pears to protect dopamine neurons from runaway excitation
(Bjo¨rklund and Lindvall, 1975; Aghajanian and Bunney, 1977;
Paladini et al., 2003; Beckstead et al., 2004; Gentet andWilliams,
2007). This has been shown to involve D2R-mediated activation
of hyperpolarizing K+ conductances (Silva and Bunney, 1988).
TIDA neurons share several features with their mesencephalic
counterparts, including co-transmitters, such as GABA (Everitt
et al., 1984) and neurotensin (Ibata et al., 1983), and the ability
to exhibit both tonic and phasic discharge configurations. It is
not known, however, whether mechanisms of autoregulation
are similar or different in TIDA cells.
Intriguingly, recent in vitro studies have revealed that TIDA
neurons in the male rat discharge in an oscillating pattern, which
can be switched to tonic discharge by hormones and neuro-
transmitters (Lyons et al., 2010, 2012; Briffaud et al., 2015)
that, in in vivo studies, have correlated to prolactin release and
lactation. This phenomenon raises the question of whether andCell Reports 15, 735–747, April 26, 2016 ª2016 The Authors 735
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
how dopamine participates in the maintenance of this rhythmic
behavior. The important question of how an oscillating circuit
tunes its activity to internal feedback is poorly understood and
ideally studied in a spontaneously active preparation. Further-
more, understanding the homeostatic regulation of TIDA neu-
rons is clinically important, as several of the most troubling
side effects associatedwith antipsychotic, aswell as antidepres-
sant, drugs derive from their ability to raise serumprolactin (Mad-
husoodanan et al., 2010; Serretti and Chiesa, 2011). The results
we present here suggest the existence of a ultra-short autoinhi-
bitory loop in TIDA neurons encompassing both pre-and post-
synaptic mechanisms that is continuously adjusted to ambient
somatodendritic dopamine levels.
RESULTS
Dopamine D2R Activation Decreases Oscillation
Frequency
The TIDA neurons in the male rat exhibit stereotyped electro-
physiological properties, including anomalous inward rectifica-
tion, an A-like current conductance, and a slow (0.05–0.07 Hz)
oscillation. This electrical profile correlates to the expression of
tyrosine hydroxylase and can reliably be used to identify these
cells for in vitro recordings (Lyons et al., 2010). Using these
criteria, we first sought to determine how TIDA network behavior
is affected by agonists of the dopamine receptors, using whole-
cell recordings.
Application of dopamine (20 mM) induced a reversible increase
of the oscillation cycle duration (+7.66 ± 1.47 s; n = 5; p < 0.05
versus control; ANOVA; Figures 1Ba–1Bd; Table S1). To identify
the different components of the cycle, a custom written analysis
program was developed (Figure 1A; Supplemental Experimental
Procedures). Thus, the dopamine-induced slowing of the oscilla-
tion was found to result primarily from an increase in phase 1
(i.e., initial slow depolarization from nadir: +5.03 ± 1.13 s;
n = 5; p < 0.05 versus control; ANOVA; Figure 1Bb; Table S1)
but also from a smaller increase in phase 3 duration (spiking
phase: +2.92 ± 0.71 s; n = 5; p < 0.05 versus control; ANOVA;
Figure 1Bb; Table S1). The duration of phases 2 (fast depolariza-
tion) and 4 (repolarization) were not affected by the application of
dopamine. Application of the non-selective dopamine receptor
agonist apomorphine (20 mM) resulted in similar changes in oscil-
lation cycle properties, as seen with dopamine (n = 5/5; Figures
1Ca–1Cd; Table S1).
Application of the D2R agonist, 20 mM quinpirole (Qp) also
caused changes to oscillation parameters indistinguishable
from those observed following dopamine application (n = 8/8;
Figure 1E; Table S1). In the presence of the D1-type-receptor
(D1R)-specific agonist, SKF-81,297 (10 mM) (Reavill et al.,
1993), however, oscillation parameters were not significantly
altered (n = 5/5; Figure 1D; Table S1). As it could not, at this point,
be excluded that ongoing dopamine release in the slice might be
acting on D1 receptors diminishing an effect of exogenous ago-
nists (Dewey et al., 1992), we also tested the D1R antagonist,
SCH-23,390 (10 mM) (Bourne, 2001), but prolonged application
of this compound did not affect oscillation parameters (n = 7/7;
Table S1). Last, we tested whether D2R activation alters
rhythmicity in the presence of fast-ionotropic blockade (FIB)736 Cell Reports 15, 735–747, April 26, 2016(100 mMpicrotoxin [Ptx], 10 mMCNQX, and 25 mMAP-5). In these
conditions, 20 mM Qp led to a prolongation of cycle duration
(5.99 ± 0.91 s; n = 6; p < 0.01 versus FIB) by increasing phase
1 and phase 3 durations (Figure S2; Table S1). These data iden-
tify D2R as an autoreceptor that modulates TIDA membrane
properties and slows down network rhythm.
D2R Antagonism Switches TIDA Neurons to
Depolarization Block
These findings raised the question of whether there is ongoing
D2R activation due to endogenous dopamine release in the
spontaneously active slice. This issue was addressed by
pharmacological antagonism of the D2R. Application of the se-
lective D2R antagonist eticlopride (1 mM) resulted in a depolar-
ization of the TIDA oscillation nadir (+2.46 ± 0.77 mV; n = 5; p <
0.05 versus control; Figures 2Aa and 2Ab; Table S1) concomi-
tant with a decrease in phase 1 duration (1.88 ± 0.65 s; n = 5;
p < 0.05 versus control; Figure 2Ab; Table S1) and an increase
of phase 3 duration (+1.51 ± 0.37 s; n = 5; p < 0.05 versus
control; Figure 2Ab; Table S1). The cycle duration remained un-
changed (0.64 ± 0.56 s; n = 5; p > 0.05 versus control; Fig-
ure 2Ab; Table S1), as predicted by the opposite changes in
the duration of phases 1 and 3. Application of a second D2R
antagonist, the typical antipsychotic haloperidol (1 mM), had
similar effects (n = 5/5; Figures 2Ba and 2Bb; Table S1). Closer
examination of the individual action potentials (APs) revealed
that application of either eticlopride or haloperidol induced a
statistically significant decrease in amplitude and broadening
of the APs (Figures 2Ad and 2Bd; Table S2). This effect on
amplitude and half-width increased in size from the first to
the fifth AP (Figures 2Ad and 2Bd; Table S2). The effect on
the waveform of the fifth AP of a cycle is demonstrated in Fig-
ures 2Ac and 2Bc.
Similar changes in AP waveform have previously been
described in midbrain dopamine neurons as a prodrome of the
depolarization block (DB) (Bikson et al., 2003; Vandael et al.,
2015; Richards et al., 1997) induced by antipsychotics (Grace
and Bunney, 1986). This similarity, and the depolarized nadir
induced by eticlopride, prompted us to examine the effects of
higher concentrations of the D2R antagonists. Application of eti-
clopride (10 mM, n = 5/5) or haloperidol (10 mM, n = 11/11) re-
sulted in a gradual depolarization and ultimate collapse of the
oscillation (Figures 2Ca and 2Cb). AP amplitude gradually
decreased and was eventually followed by a complete loss of
APs concurrent with the collapse of the oscillation (Figures 2Ca
and 2Cb). Injection of depolarizing square current pulses re-
sulted only in a single, low-amplitude AP, verifying that the ca-
pacity for regenerative firing was compromised (Figure 2Cc).
Collectively, these results suggest that TIDA neurons respond
to D2R antagonists by excitation, leading to DB in a manner
highly similar to what has been described in midbrain dopamine
neurons following chronic application of dopamine antagonist
antipsychotics (Grace and Bunney, 1986).
Dopamine Reuptake at the Cell-Body Level Regulates
TIDA Oscillations
The partly opposite effects of D2R agonists and antago-
nists suggest that the baseline behavior of TIDA neurons may
Figure 1. D2R Activation Decreases TIDA Neuron Oscillation Frequency
(A) Current-clamp recording from TIDA neuron illustrating one cycle of the oscillation divided into four phases based on changes in slope (dV/dt).
(Ba–Bd) In (Ba), dopamine application leads to a reversible decrease in oscillation frequency (0.017 ± 0.004 Hz, p < 0.05, n = 5). (Bb) Expanded and overlaid
boxed traces from (Ba) (gray trace indicates control, black trace indicates dopamine), and population data show a large increase in phase 1 duration (+5.03 ±
1.13 s) and a smaller increase in phase 3 duration (+2.92 ± 0.71 s; p < 0.05; n = 5). (Bc) Membrane voltage distribution plot illustrates accentuated biphasic
distribution in the presence of dopamine. (Bd) Histogram demonstrating a reversible decrease of the oscillation frequency by dopamine.
(Ca–Cd) Organized as in (Ba)–(Bc), (Ca)–(Cc) illustrate a similar slowing effect on oscillation by apomorphine as by dopamine; increases in phase 1 (+17.28 ±
3.09 s) and phase 3 (+1.76 ± 0.56 s) duration (p < 0.05, n = 5). Apomorphine-induced accentuation of biphasic membrane voltage distribution as shown in (Cc).
(Cd) Histogram demonstrating a reversible increase in phase 1 duration by apomorphine.
(D and E) Organized as in (Ba). (D) Application of the D1R-agonist, SKF-81,297, does not alter cycle or phase durations (n = 5). (E) Application of the D2R receptor
agonist, Qp (n = 8), decreases oscillation frequency (0.013 ± 0.001 Hz; p < 0.0001) and increases the duration of phases 1 (+6.61 ± 1.76 s; p < 0.01) and
3 (+1.23 ± 0.38 s; p < 0.05). Note similarity to dopamine and apomorphine effects (Ba, Bb, Ca, and Cb).
ns, not significant.depend on continuous dopaminergic feedback. To further
explore endogenous dopamine release in the dmArc we inves-
tigated the effect of blocking the dopamine transporter (DAT).
The existence of the DAT in the TIDA system is controversial.
Evidence has been presented for both the absence (Demarest
and Moore, 1979b; Annunziato et al., 1980) and existence (De-
maria et al., 2000; Bosse´ et al., 1997) of functional dopaminereuptake in these cells. We addressed this issue directly
by applying a DAT blocker, either GBR-12783 or methylpheni-
date, and recorded the electrophysiological response. In the
presence of GBR-12783 (1 mM) and methylphenidate (50 mM),
TIDA neurons exhibited changes similar to those elicited by
D2R agonists, i.e., dopamine, apomorphine, and Qp, and
slowed down oscillation frequency (GBR-12783, n = 8/8;Cell Reports 15, 735–747, April 26, 2016 737
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methylphenidate, n = 5/5; Figures 2Da and 2Db; Table S1).
While both phases 1 and 3 were significantly prolonged in the
presence of methylphenidate, the application of GBR-12783
only resulted in a significantly increased duration of phase 1.
These data suggest the existence of endogenous release of
dopamine from TIDA neurons and the presence of functional
dopamine reuptake at the somatic level in these cells. Next,
we sought to identify the membrane actions that underlie the
D2R-mediated modulation of TIDA neurons.
D2R Activation Causes a Cs+-Sensitive
Hyperpolarization
Application of tetrodotoxin (TTX; 0.5 mM) abolishes the TIDA
oscillation (Lyons et al., 2010) likely owing to the inhibition of a
persistent Na+ current. Under these conditions, and with mem-
brane potential set to 60 mV via negative current injection,
application of Qp (20 mM) resulted in a hyperpolarization of
4.19 ± 0.78 mV (n = 6; p < 0.01 versus control; Figures 3A
and 3C). This hyperpolarization was attenuated when Qp was
applied to cells recorded with an intracellular solution containing
Cs+ (p < 0.05 versus Qp) (1.69 ± 0.45mV; n = 9; p < 0.05 versus
control; Figures 3A–3C). While Cs+ is known to block h current
(Ih), the ability of intracellularly applied Cs
+ to attenuate this cur-
rent is controversial (Harris and Constanti, 1995). Thus, to more
specifically test whether the phase 1 prolongation byD2R activa-
tion is partly an effect involving Ih, Qp was co-applied with the Ih
blocker ZD-7288 (10 mM). Under these conditions, application of
Qp failed to significantly increase phase 1 duration, whereas a
prominent prolongation of phase 3 remained (Figures 3D and
3E). These findings suggest a D2R-mediated decrease of Ih.
D2R Agonism Inhibits an Inward Current Operating at
High Voltage
To characterize the ionic currents modulated by D2R agonism,
TIDA neurons were recorded in voltage-clamp mode in the
presence of TTX (0.5 mM) at a holding potential (VHold)
of 60 mV, i.e., at which the Qp-induced hyperpolarization
had been observed. Application of Qp (20 mM) did not signifi-
cantly affect holding current under these conditions (0.49 ±
1.5 pA; n = 6; p > 0.05 versus control; Figure 3F). To determine
current changes that might occur throughout the membrane
potential spectrum, a voltage-clamp ramp protocol of 500-ms
durations was used, allowing the identification of D2R-medi-Figure 2. D2R Antagonism and DAT-Blockade Effect on TIDA Neurons
(Aa–Ad) In (Aa) and (Ab), a current-clamp recording from oscillating TIDA neuron is
in AP amplitude and depolarization of the nadir (horizontal gray bars). Boxed sec
indicates eticlopride), with population data shown in the histogram; note the dec
duration (+1.51 ± 0.37 s) (p < 0.05, n = 5). (Ac) Averaged (indicated by solid lines, S
(Ad) Average AP amplitude (green) progressively decreases and half-width (re
(indicated by a dashed line; solid line indicates control).
(Ba–Bd) Organized as in (Aa)–(Ad), respectively, these panels illustrate the simila
(Ca–Cc) In (Ca), following application of 10 mM eticlopride, TIDA neurons progres
abolished (n = 5/5). Inset shows the same effect with 10 mM haloperidol (n = 11
responses to step current pulses in control (Cb i) and after a 40-min application
(Da and Db) Effect of DAT antagonists on oscillation frequency. (Da) Application of
control) via phase 1 prolongation (3.64 ± 1.41 s; n = 8; p < 0.05 versus control).
p < 0.01 versus control) via phase 1 (+2.38 ± 0.38 s) and, to a smaller extent, ph
ns, not significant.ated currents throughout the voltage spectrum of 115 mV
to 0 mV (Figure 3Ga). Digital subtraction of the ramp performed
with control versus Qp (Figure 3Gb) revealed a Qp-induced
current (IQp) that was a non-reversing net outward current,
active only at membrane potentials positive of approxi-
mately 45 mV (n = 5; Figure 3Gc), increasing with depolariza-
tion within the range tested (VHold = 0 mV; +124.83 ± 34.97 pA).
At a VHold negative of 50 mV no prominent IQp is evoked, sug-
gesting that the Cs+-sensitive current underlying the phase 1
depolarization (discussed earlier) is not of sufficient amplitude
to be isolated under these conditions.
D2R Activation Inhibits High-Voltage-Activated Ca2+
Channels in TIDA Neurons
The IQp may reflect the activation of an outward current and/or
the inhibition of an inward current. As the I-V relationship of IQp
is similar to that of a reversed ICa
2+ (Nowycky et al., 1985; Fedu-
lova et al., 1985), we tested whether D2R stimulation decreased
Ca2+ flux in TIDA neurons, using a voltage ramp protocol.
Application of Qp (20 mM) was followed by a substantial and
significant decrease of the high-voltage-activated (HVA) Ca2+
currents (52.71 ± 9.09 pA; n = 7; p < 0.01 versus control;
Figure 4A). Control experiments did not identify a prominent
low-voltage-activated, T-type Ca2+ current in TIDA neurons
(Figure 4A). Application of the L-type-specific blocker nimodi-
pine (10 mM), however, attenuated the Ca2+ current (62.8 ±
19.04 pA; n = 5; p < 0.05 versus control, ANOVA; Figure 4B). Un-
der L-type Ca2+ channel blockade, the Qp-induced decrease in
HVA current was significantly diminished (34.6 ± 9.42 pA; n = 5;
p < 0.05 versus nimodipine, ANOVA; Figure 4B). Application of
the N-type-specific Ca2+ channel blocker u-conotoxin GVIA
(1 mM) decreased the Ca2+ currents (71.4 ± 22.72 pA; n = 5;
p < 0.05 versus control, ANOVA; Figure 4C). Under N-type
Ca2+ channel blockade, application of Qp (20 mM) resulted in a
small, but significant, decrease of the remaining Ca2+ current
(7.8 ± 1.91 pA; n = 5; p < 0.05 versus control, ANOVA; Fig-
ure 4C). Last, upon co-application of nimodipine and u-cono-
toxin GVIA, the Ca2+ current decreased dramatically (119.4 ±
6.94 pA; n = 5; p < 0.001 versus control, one-way ANOVA; Fig-
ure 4D). In these conditions, application of Qp (20 mM) failed to
induce a significant decrease of the remaining Ca2+ current
(10.6 ± 5.32 pA; n = 5; p > 0.05 versus control, ANOVA;
Figure 4D).shown. Application of eticlopride (1 mM) is followed by a progressive decrease
tions from (Aa) are expanded and overlaid in (Ab) (gray indicates control; black
rease in the phase 1 duration (1.88 ± 0.65 s) and the increase in the phase 3
E in shading) APs in the absence (green) and presence (red) of 1 mMeticlopride.
d) increases during the oscillation cycle in the presence of 1 mM eticlopride
rity of effects of 1 mM haloperidol and eticlopride.
sively depolarize, with the oscillation ultimately collapsing and AP firing being
/11). (Cb) Boxed sections in (Ca) are expanded in (Cb i)–(Cb iv). (Cc) Voltage
of 10 mM eticlopride (Cb iv) show a loss of capacity for repetitive discharge.
GBR-12783 (1 mM) prolongs cycle duration (3.49 ± 1.25 s; n = 8; p < 0.05 versus
(Db) Similarly, methylphenidate increases cycle duration (2.62 ± 0.44 s; n = 5;
ase 3 (+1.06 ± 0.18 s) (p < 0.01, n = 5).
Cell Reports 15, 735–747, April 26, 2016 739
Figure 3. D2R Activation Induces a Postsynaptic Outward Current Operating at a Depolarized Membrane Potential
(A) Current-clamp recording of a TIDA neuron in the presence of TTX to abolish oscillation and APs. Note hyperpolarization following application of Qp.
(B) Recording under the same conditions as in (A) but with cesium methanesulfonate included in the intracellular solution; note the attenuation of Qp-induced
hyperpolarization.
(C) Average membrane potential in control, with Qp applied (4.19 ± 0.78 mV; n = 6; p < 0.01), and Qp applied in the presence of intracellular cesium (1.69 ±
0.45 mV; n = 9; p < 0.01).
(D) Current-clamp recording of a TIDA neuron in the presence of ZD-7288 and co-application of Qp. Under these conditions, cycle duration increase is attrib-
utable exclusively to phase 3 prolongation (4.25 ± 1.38 s; n = 6; p < 0.05 versus ZD-7288).
(E) D2R activation under Ih blockade does not lead to phase 1 prolongation (2.67 ± 3.3 s; n = 6; p > 0.05 versus ZD-7288).
(F) Voltage-clamp recording of a TIDA neuron in the presence of TTX at a holding potential of 60 mV. Under these conditions, Qp does not significantly affect
membrane current (0.49 ± 1.5 pA; n = 6; p > 0.05). Population data in the inset show control in black and Qp in blue (solid lines indicate average; shaded area
indicates SE.
(Ga–Gc) Inset shows voltage-clamp ramps: 115 to 0 mV; 500-ms (Ga–Gc) recordings of TIDA neurons in the absence (black) and presence (blue) of Qp
(averaged traces; (Gb) n = 5). (Gc) Qp-induced current. Note the minimal current flowing between 115 and 50 mV and large inward current activated at
depolarized voltage (> 50 mV).
ns, not significant.
740 Cell Reports 15, 735–747, April 26, 2016
Figure 4. D2R Activation Decreases Ca2+
Currents in TIDA Neurons through L- and
N-Type Ca2+ Channels
(A) Average voltage-clamp ramp traces recorded
from TIDA neurons (ns = 7/5/5/5 for A–D, respec-
tively) under pharmacological isolation of Ca2+
currents. Current recorded under control condi-
tions shown in green (solid lines, average; shaded
area, SE). Note the attenuation of HVA Ca2+ cur-
rents in the presence of Qp (blue). Inset shows
average current at peak in control (154.9 ±
25.44 pA) and upon Qp application (102.1 ±
19.10 pA, n = 7, p < 0.01 versus control).
(B) Organized as (A), but with recording in the
presence of the L-type HVA current antagonist,
nimodipine (blue), and nimodipine and Qp co-
applied (red). The control HVA Ca2+ current (205 ±
21.55 pA) is decreased following the application of
nimodipine (142.2 ± 18.78 pA, n = 5, p < 0.05
versus control), upon which Qp has a diminished
effect (107.6 ± 10.49 pA; n = 5; p < 0.05 versus
nimodipine).
(C) Organized as in (A), but with recording in the
presence of the N-type HVA current antagonist,
GVIA-conotoxin (blue), and GVIA-conotoxin and
Qp co-applied (red). The control HVA Ca2+ current
(141.2 ± 22.77 pA) is decreased by application of
GVIA-conotoxin (69.8 ± 4.55 pA; n = 5; p < 0.05
versus control), upon which Qp has aminiature yet
significant effect (62 ± 5.54 pA; n = 5; p < 0.05
versus GVIA-conotoxin).
(D) Organized as in (A), but with recording in the
presence of nimodipine andGVIA-conotoxin (blue)
and of nimodipine, GVIA-conotoxin, and Qp
co-applied (red). The control HVA Ca2+ current
(194.2 ± 21.55 pA) is markedly decreased when
both L- and N-type channels are blocked (74.8 ±
16.18 pA; n = 5; p < 0.001 versus control). Under
these conditions, application of Qp does not
further decrease HVA currents (64.2 ± 11.56 pA;
n = 5; p > 0.05 versus GVIA-conotoxin and nimo-
dipine). Data are presented in absolute values.
(Ea and Eb) Effect of (Ea) ‘‘low-Ca2+’’ aCSF on the
TIDA oscillation and (Eb) phase 3 duration, which
is increased (59.98 ± 24.45 s; n = 7; p < 0.05 versus
control).
(Fa–Fc) Current-clamp (Fa) and voltage-clamp (Fb)
recordings in the presence of nimodipine,
demonstrating (Fc) phase 3 prolongation (18.33 ±
7.61 s; n = 8; p < 0.05 versus control).
(Ga–Gc) In (Ga), a current-clamp recording is
shown in the presence of the BK channel blocker,
charybdotoxin (200 nM). (Gb) Recording in (Ga),
shown in higher temporal resolution; control (light
green) versus charybdotoxin (gray). Note the pro-
longation of phase 3 and discharge. (Gc) BK
channel blockade leads to a significant prolonga-
tion of phase 3 (6.41 ± 1.85 s; n = 8; p < 0.05 versus
control).
ns, not significant.Interplay of BK Channels and Ca2+ Influx Controls
Phase 3
To assess whether this D2R-mediated decrease in L-type Ca2+
currents could prolong phase 3 duration, short applications of
low-Ca2+/high-Mg2+ artificial cerebrospinal fluid (aCSF) wereperformed. A reversible phase 3 prolongation was demon-
strated under these conditions (59.98 ± 24.45 s; n = 7; p <
0.05 versus control; Figures 4Ea and 4Eb). Similarly, application
of nimodipine resulted in prolongation of phase 3 (18.33 ± 7.61
s; n = 8; p < 0.05 versus control) in current-clamp (n = 4) as wellCell Reports 15, 735–747, April 26, 2016 741
Figure 5. Phase-Dependent Modulation of
sIPSC Frequency via D2R Agonism
(Aa–Ac) In (Aa), a voltage-clamp recording from
TIDA neurons is shown, in the presence of iono-
tropic glutamate receptor antagonists and using
high [Cl]i to isolate sIPSCs. Phase 1 is indicated
by light blue, and phase 3 is indicated by dark blue.
(Ab) The sIPSC IEI is significantly lower in phase 3
than in phase 1 (112.5 ± 32.55 ms; n = 5; p <
0.05), whereas the sEPSC IEI is not significantly
different (57.07 ± 30.5 ms; n = 6; p > 0.05). (Ac)
The amplitude of sIPSCs (+4.81 ± 3.87 ms; n = 5;
p > 0.05, phase 3 versus phase 1) and sEPSCs
(+0.19 ± 0.46 ms; n = 6; p > 0.05) is not different
between phases 1 and 3.
(Ba–Bc) In (Ba), raw voltage-clamp phase 1 traces
are shown in the absence (top) and presence
(bottom) of Qp. (Bb) Cumulative frequency distri-
bution of the sIPSC IEI, demonstrating a signifi-
cant increase in sIPSC frequency (125.0 ±
40.09 ms; KS-2 p < 0.05; t test p < 0.05; n = 5)
during phase 1 after application of Qp. (Bc)
Phase 1 sIPSC amplitude remains unchanged by
Qp (+1.39 ± 3.19 pA; KS-2 p > 0.05; t test p > 0.05;
n = 5).
(Ca–Cc) In (Ca), raw voltage-clamp phase 3 traces
are shown in the absence (top) and presence
(bottom) of Qp. (Cb) Cumulative frequency distri-
bution of the sIPSC IEI demonstrating a decrease
in sIPSC frequency (+60.43 ± 21.61 ms, KS-2 p <
0.05; t test p < 0.05; n = 5) during phase 3 in the
presence of Qp. (Cc) Phase 3 sIPSC amplitude is
not affected (0.34 ± 4.75 pA; KS-2, p > 0.05;
t test, p > 0.05; n = 5).
ns, not significant.as voltage-clamp (n = 4) recordings (Figures 4Fa–4Fc). As Ca2+
influx through L-type channels has commonly been implicated
in the activation of Ca2+-dependent K+ channels (e.g., (Marrion
and Tavalin, 1998), we last applied the big conductance Ca2+-
activated K+ channel (BK) antagonist, charybdotoxin (200 nM).
In the presence of charybdotoxin, phase 3 was also signifi-
cantly increased in duration (6.41 ± 1.93 s; n = 8; p < 0.05
versus control). These data suggest that TIDA D2R activation
leads to inhibition of the L-type (Cav1.1-1.4) and N-type
(Cav2.2) HVA Ca
2+ channels accounting for the prolongation
of phase 3, possibly via the interplay of Ca2+ and BK channels
responsible for phase 3 termination.
D2R Phase-Dependent Modulation of Rhythmic
Inhibitory Input
Next, we investigated whether, in addition to postsynaptic
modulation of TIDA membrane currents, D2R stimulation also
affects synaptic input to these neurons. The frequency of inhib-
itory synaptic input in TIDA neurons is higher in phase 3 than in
phase 1 (Lyons et al., 2010) (Figures 5Aa–5Ac; phase 1: spon-742 Cell Reports 15, 735–747, April 26, 2016taneous inhibitory post-synaptic cu-
rrent (sIPSC) inter-event interval (IEI) =
335.5 ± 56.57 ms; phase 3: sIPSC IEI =
223 ± 45.18 ms; difference in means ±SEM, 112.5 ± 32.55 ms; p < 0.05; n = 5). This discrepancy
may reflect different sources of inhibitory input onto TIDA neu-
rons across the oscillatory cycle. IPSCs were, therefore,
compared separately in phase 1 and phase 3. The IEI for
sIPSCs in the presence of Qp (20 mM) was significantly
decreased during phase 1 (125 ± 40.09 ms; n = 5; Figures
5Ba and 5Bb; KS-2, p < 0.05 versus control; t test, p < 0.05
versus control; Figures 5Ba and 5Bb) but significantly
increased during phase 3 (+60.43 ± 21.62 ms; n = 5; Figures
5Ca and 5Cb; KS-2, p < 0.05 versus control; t test, p < 0.05
versus control; Figures 5Ca and 5Cb). In contrast, the ampli-
tude of sIPSC was not affected by Qp application during either
phase 1 (+1.39 ± 3.19 pA; n = 5; Figure 5Bc; KS-2, p > 0.05
versus control; t test, p > 0.05 versus control; Figures 5Ba
and 5Bc) or phase 3 (+0.34 ± 4.75 pA; n = 5; Figure 5Cc;
KS-2, p > 0.05; t test, p > 0.05; Figures 5Ca and 5Cc). Analysis
of spontaneous excitatory postsynaptic currents (sEPSCs) re-
vealed no significant changes (Figure S3). Likewise, miniature
IPSCs and EPSCs (recorded in the presence of 0.5 mM TTX)
were affected neither in IEI nor in amplitude (Figure S4). Taken
Figure 6. Increased GABAA-Mediated Inhi-
bition Contributes to D2R-Mediated Slow-
ing of Oscillation Frequency by Extending
Phase 1
(A) Overlaid current-clamp recordings from oscil-
lating TIDA neuron in the presence of Ptx before
(gray) and during (black) application of Qp. Acti-
vation of the D2R induces an increase in cycle
duration (+3.49 ± 1.13 s; p < 0.05 versus Ptx; n = 6)
by increasing the duration of phases 1 (+1.86 ±
0.59 s; p < 0.05 versus Ptx; n = 6) and 3 (+1.32 ±
0.15 s; p < 0.001 versus Ptx; n = 6).
(B) Experiment is as in (A), but with addition of
CGP-55845 (CGP) in the bath to block GABAB
receptors. When Qp is added, increases in the
duration of the oscillation cycle (+4.43 ± 1.45 s; p <
0.05 versus Ptx + CGP; n = 5), phase 1 (+1.76 ±
0.51 s; p < 0.05 versus Ptx + CGP; n = 5), and
phase 3 (+1.89 ± 0.68 s; p < 0.05 versus Ptx +
CGP; n = 5) are seen also under these conditions.
Scale bars, as shown in (A).
(C–E) Comparison of the increases in cycle (C),
phase 1 (D), and phase 3 (E) duration induced by
Qp application in control conditions (n = 7) versus
during GABAA (n = 6) or combined GABAA/B (n = 5)
blockade. (C) The increase in cycle duration
following Qp alone (7.95 ± 2.17 s) is significantly
larger than the increases seen in Ptx + Qp (3.49 ±
1.13 s; p < 0.05) and Ptx + CGP + Qp (4.43 ±
1.45 s; p < 0.05). In contrast, the increase
measured in Ptx + Qp was not significantly
different from the increase in Ptx + CGP + Qp. (D)
Similarly, the increase in the duration of phase 1
following Qp alone (6.61 ± 1.76 s) is significantly
greater than the increases seen for Ptx + Qp
(1.86 ± 0.59 s; p < 0.05) and Ptx + CGP + Qp
(2.22 ± 0.78 s; p < 0.05); increases recorded in
Ptx + Qp and Ptx + CGP + Qp are not significantly
different from each other. (E) The increases in the
duration of phase 3 recorded in Qp (1.23 ± 0.38 s),
Ptx + Qp (1.32 ± 0.15 s) and Ptx + CGP + Qp
(1.89 ± 0.68 s) are not different from each other.
ns, not significant.together, these data suggest that D2R stimulation increases
inhibitory input during phase 1, while it decreases it during
phase 3.
GABAA Receptor Blockade Attenuates the D2R
Activation Effect on Oscillation Frequency
The Qp-induced increase in sIPSC frequency during phase 1
suggests the possibility that the D2R-mediated decrease of
oscillation frequency may be partly caused by augmented syn-
aptic inhibition. If so, the effect of Qp on phase 1 should be
diminished or abolished in the absence of GABAA-mediated inhi-
bition. Thus, Ptx (100 mM) was bath applied prior to Qp (20 mM)
application. Under these conditions, the Qp-mediated increase
in cycle duration via prolongation of phase 1 was diminished
by 48% (Figures 6A and 6C–6E; n = 6). Importantly, the Qp-
induced increase in phase 3 duration was not affected by Ptx
application (Figure 6E; n = 6; p > 0.05). The combined blockade
of GABAA (by Ptx) and GABAB receptors (by the antagonist,
CGP-55845; 10 mM) did not produce any additional attenuationof theQp-mediated increase in cycle period or phase 1 or 3 dura-
tion, compared to Ptx alone (n = 5; Figures 6B–6E; Table S1).
These data demonstrate that increased GABAA transmission
contributes to dopaminergic autoregulation of the TIDA oscilla-
tion frequency, acting within the same membrane potential
spectrum as, and likely parallel to, a Cs+-sensitive hyperpolariz-
ing postsynaptic current (Figures 3A–3C).
DISCUSSION
Feedback regulation is a core feature of CNS circuits. In the
neuroendocrine system, such regulation has generally been
studied in the context of multicomponent feedback loops,
involving actions of the corresponding pituitary hormone—or a
peripheral target hormone—on the hypothalamic ‘‘master’’ pop-
ulation. In the lactotrophic axis, prolactin can stimulate both
dopamine production (Clemens and Meites, 1968; Ho¨kfelt and
Fuxe, 1972; Demarest et al., 1986; Gonzalez et al., 1988) and
AP discharge and waveform (Lyons et al., 2012; Brown et al.,Cell Reports 15, 735–747, April 26, 2016 743
2012) in TIDA cells to increase the suppression of its own release
in the pituitary. However, the possibility that parvocellular
neurons can autoregulate their own activity, as ameans of imme-
diate homeostatic tuning, has received little attention. In gonad-
otropin-releasing-hormone (GnRH)-expressing neurons, there is
evidence of an ‘‘ultra-short feedback loop’’ (Bedran de Castro
et al., 1985) involving modification of the electrical activity (Xu
et al., 2008). In TIDA neurons, the literature offers conflicting ev-
idence for (Berry and Gudelsky, 1991; Liang and Pan, 2001) and
against (Demarest and Moore, 1979a; Durham et al., 1997; Tim-
merman et al., 1995) the existence of autoreceptors. Importantly,
the possibility thatmembrane properties and network activity are
targeted by autoreceptors has not been explored on identified
TIDA neurons.
Our experiments reveal that increasing D2R activation causes
two coincident changes in the TIDA duty cycle: a prolonged
duration of phase 1, resulting in a slower oscillation, followed
by a minor prolongation of phase 3. The similar reconfiguration
of the oscillation following the exogenous application of Qp, as
when ambient endogenous dopamine was increased by GBR-
12783 and methylphenidate induced DAT blockade (although
the former prolonged only phase 1), strongly indicates that these
effects are not simply pharmacological. It should be stressed
that the present results do not unequivocally rule out dopami-
nergic sources other than TIDA neurons as the endogenous
ligand source for autoreceptors. Indeed, the term ‘‘autorecep-
tor’’ commonly refers to a receptor whose ligand is produced
by the same neuron; it does not, as such, posit that the ligand
is exclusively supplied by that cell. However, given that the slice
preparation used here likely includes little of dopamine popula-
tions outside of the A12 group, the results using receptor and
DAT blockers favor the interpretation that TIDA neurons are
capable of autoregulation.
Our results further suggest that DATs are located at release
sites within the dmArc, i.e., where the cell bodies of TIDAs
are located. The functional expression of DAT within the TIDA
system has been controversial, with arguments presented
both for its absence (Lookingland et al., 1987) and for its pres-
ence (Bosse´ et al., 1997; Demaria et al., 2000). However, this
discussion has largely been based on the assumption that
TIDA DATs are located on axon terminal release sites (i.e., in
the ME). Therefore, the point in question may not be whether
TIDAs have DATs but rather the site of the transporter’s ac-
tions. Our finding in which somatic whole-cell electrophysiology
responds to DAT blockade in the same manner as following
D2R stimulation indicates that DAT may be present and func-
tional also on release sites that target the TIDA cell-body re-
gion. The exact nature of such release sites remains to be
elucidated. Ultrastructural studies have shown that recurrent
axon collaterals from TIDA neurons do not appear to form
synaptic contacts, but extensive dendrodendritic and somatic
contacts exist among these cells (Piotte et al., 1985). This
anatomical organization is thus consistent with local release
of dopamine—from dendrites and/or non-synapse forming
axon collaterals—in the service of autoregulation, analogous
to what has been observed in the midbrain dopamine neurons
(Bjo¨rklund and Lindvall, 1975; Geffen et al., 1976; Ford et al.,
2010).744 Cell Reports 15, 735–747, April 26, 2016The modulation of phases 1 and 3 by D2R stimulation is medi-
ated via distinct effects. At amembrane potential of60mV, i.e.,
within the phase 1 range, D2R activation induces a hyperpolar-
ization, suggesting the contribution of direct post-synaptic ac-
tions. The current underlying the relatively modest (albeit with
an impact at the network level) hyperpolarization is difficult to
extract in voltage-clamp gap-free or ramp recordings; in TIDA
neurons, this has yet only been reported with currents inducing
several-fold larger changes in membrane potential (Lyons
et al., 2010, 2012; Briffaud et al., 2015). Pharmacological
experiments, however, showed that the hyperpolarization is
diminished by intracellular Cs+, implicating an increased K+
conductance and/or an inhibition of the hyperpolarization-acti-
vated cation current (Ih). Evidence for each has been reported
frommidbrain dopamine neurons (Lacey et al., 1987; Momiyama
et al., 1993; Jiang et al., 1993). Here, the increase in phase 1
duration by D2R activation was abolished during Ih blockade,
suggesting Ih as a mediator of the effect of D2R activation during
phase 1.
An increased frequency of sIPSCs was also observed by D2R
activation, raising the possibility that augmented phasic in-
hibition contributes to the slowing of this phase. Notably, the
increase in the duration of phase 1 was significantly attenuated
when Qp was applied during GABAA blockade (by Ptx). Thus,
simultaneous increases in presynaptic inhibition and postsyn-
aptic K+ or Ih-mediated outward current underlie the changes
in phase 1 that primarily account for the decreased frequency re-
sulting from an increased dopaminergic tone. As TIDA neurons
do not discharge during phase 1, the increased inhibitory input
is likely generated by another local neuronal population.
Phase 3 occupies a relatively depolarized membrane potential
space, overlapping with the changes in HVA Ca2+ currents that
followedD2R activation in TIDA neurons. Previous work has sug-
gested the existence of L-type Ca2+ currents in these cells
(Lyons et al., 2012). Our results confirm this and reveal the pres-
ence of N-type Ca2+ channels in TIDA neurons; the existence of
P/Q and R-type Ca2+ channels remains to be investigated. We
show that reductions in both L- and N-type Ca2+ currents
contribute to the HVA IQp. Attenuated inward currents may
seem counterintuitive as an explanation for the extended depo-
larized plateau of phase 3. However, TIDA neurons also exhibit
Ca2+-dependent K+ currents (Lyons et al., 2012), and pharmaco-
logical inhibition of IK(Ca
2+
) results in an increased duration of
phase 3, as shown in Figure 4. Thus, the attenuation of HVA
Ca2+ currents accounts for the prolonged depolarization and
discharge during D2R autoreceptor activation in TIDA neurons,
possibly due to a decreased activation the IK(Ca
2+
) that ultimately
causes repolarization to the nadir. The decreased synaptic inhi-
bition during phase 3 (Figure 5Ca), though it does not in itself
significantly contribute to prolonging the depolarized state,
may add a synergistic net excitatory influence.
The mechanisms we identify here suggest an additional level
of control in the neuroendocrine systemwhere TIDA neurons ho-
meostatically tune their activity to variations in the ambient extra-
cellular levels of dopamine at the somatodendritic compartment.
As local dopamine volume transmission increases (mimicked by
Qp administration or DAT inhibition), a compensatory slowing of
the network rhythm is initiated. The D2R and DAT are critical
molecular components of this tuning. In addition, the gap junc-
tion connectivity between TIDA neurons (Lyons et al., 2010)
may provide efficient transduction of the D2R-induced changes
throughout the network.
Notably, Paladini et al. (2003) have shown that when midbrain
dopamine neurons are depleted of dopamine, burst firing is lost,
suggesting that this type of feedback tuning may have general
relevance for how the discharge pattern is controlled in dopa-
mine neurons. This ultra-short loop impacts on TIDA neurons
in a manner less dramatic than that for the feedback relayed
via prolactin; while prolactin shifts discharge into tonic firing
(Lyons et al., 2012), dopamine—even at high concentrations—
maintains TIDA neurons in an oscillatory configuration but re-
structures phase relationships. It may be speculated that, as
the distance between the feedback signal (i.e., effector hormone
versus inherent transmitter) and the controlled system increases,
more radical correcting actions may be required, as deviations
from the set point have lasted for a longer time. Curiously,
some degree of continuous D2R-mediated feedback appears
necessary for the system to discharge. Gradual diminishment
of this signal, as mimicked with low doses of eticlopride and
haloperidol, results in changes generally opposite to those
induced by D2R stimulation combined with blunting of spikes.
Higher doses and longer application of the antagonists results
in depolarization block and collapse of the oscillation, rendering
the cell incapable of repetitive spiking. The DB that we demon-
strate in TIDA neurons is, in vital ways, similar to what can be
observed in midbrain dopamine neurons (Grace and Bunney,
1986) and has been proposed to provide a physiological mech-
anism that constrains a cell’s firing frequency within a limited
range, adding low-pass filter properties to a system (Wong
et al., 2013).
Finally, our findings have clinical implications. Haloperidol and
other antipsychotic drugs with D2R blocking properties at con-
centrations below the effective therapeutic dose cause hyper-
prolactinemia (Gruen et al., 1978), and associated reproductive
dysfunctions such as impotence, menstrual disturbances, and
infertility, commonly resulting in drug withdrawal (Serretti and
Chiesa, 2011). This effect is usually attributed to haloperidol
relieving pituitary lactotrophs of the tonic hyperpolarizing influ-
ence of D2R activation (MacLeod and Lehmeyer, 1974). The pre-
sent results indicate, however, that dmArc TIDA autoreceptors
may also contribute to such hyperprolactinemia by mediating
D2R-antagonist-induced DB, causing the cessation of discharge
and attenuated or abolished dopamine release in the portal ves-
sels and removing inhibition from the lactotrophs. Thus, parallel
actions of haloperidol at the somatodendritic level and at the
endocrine target in the pituitary may underlie the reproductive
side effects of D2R-active antipsychotic drugs. Thus, DB may
be a mechanism that underlies not only the therapeutic actions
of antidopaminergic antipsychotics (Grace et al., 1997) but
also the adverse sexual effects commonly caused by these
drugs.
In conclusion, our results using a spontaneously active
neuroendocrine dopaminergic preparation reveal an ultra-
short feedback pathway. These data suggest a rapid and
continuous tuning of membrane rhythm to the circuit’s own ac-
tivity echoed in fluctuations of ambient somatodendritic levelsof transmitter, and mediated by a combination of pre- and
post-synaptic actions. This arrangement may be important
both for maintaining physiologically appropriate prolactin
levels and for the development of neuroleptic-induced repro-
ductive side effects.
EXPERIMENTAL PROCEDURES
Acute slices of the mediobasal hypothalamus were prepared from 21- to 31-
day-old male Sprague-Dawley rats (Charles River Laboratories). All animal
experiments had received previous approval from the local ethical board,
Stockholm’s Norra Djurfo¨rso¨ksetiska Na¨mnd, and were performed in accor-
dance with the European Communities Council Directive of November 24,
1986 (86/609/EEC). Slices were cut on a vibratome to 250-mm thickness
and continuously perfused with oxygenated aCSF containing (in millimolar):
127 NaCl, 2.0 KCl, 1.2 NaH2PO4, 26 NaHCO3, 1.3 MgCl2, 2.4 CaCl2, and
10 D-glucose, at room temperature during recording, unless stated other-
wise. To identify the role of Ca2+ on oscillation parameters, ‘‘low-Ca2+’’ extra-
cellular recording solution was used (in millimolar): 127 NaCl, 1.9 KCl, 1.2
NaH2PO4, 26 NaHCO3, 4.5 MgSO4, 0.15 CaCl2, and 10 D-glucose. Each slice
was exposed only to a single bath application of pharmacological com-
pounds and was used for a single experiment. Whole-cell current- and
voltage-clamp recordings were performed with micropipettes filled with
intracellular solution containing (in millimolar), 140 K-gluconate, 10 KCl,
10 HEPES, 10 EGTA, and 2 Na2ATP (pH 7.3) (with KOH), unless stated other-
wise. Recordings were performed using a Multiclamp 700B amplifier,
a DigiData 1440 digitizer, and pClamp10.2 software (Molecular Devices).
Slow and fast capacitative components were automatically compensated.
Access resistance was monitored throughout the experiments, and neurons
in which the series resistance exceeded 15 MU or changed R20% were
excluded from the statistics. Liquid junction potential was 16.4 mV and not
compensated. The recorded current was sampled at 10 kHz and filtered at
2 kHz. Recordings were performed using a Multiclamp 700B amplifier,
a DigiData 1440 digitizer, and pClamp10.2 software (Molecular Devices).
To control for any effect on the oscillation due to long-time recording inter-
vals, we performed recordings of up to 100 min without adding any drug (Fig-
ure S1); rhythmic behavior was maintained, and cycle duration did not
change significantly over time. For details on in vitro electrophysiology, see
Supplemental Experimental Procedures.
Statistical Analysis
Data analysis was performed with GraphPad Prism 6, Clampfit software
(Molecular Devices), AxoGraph, OriginPro 8 (OriginLab), and custom written
MATLAB scripts. Phase analysis for each recording was based on data ob-
tained over five consecutive oscillation cycles. Control traces were collected
after 10 min of baseline and immediately followed by drug application. Post-
synaptic currents were analyzed using Mini Analysis 6.0.9 (Synaptosoft).
Detection threshold was set at 3-fold the root-mean-square (RMS) noise level,
which typically was 3–6 pA. Frequency, inter-event interval, and amplitudes
were calculated as a mean of the values obtained during a 60-s recording
period. For postsynaptic current phase analysis, 3-s samples of phase 1 and
1-s samples of phase 3 of three consecutive oscillation cycles were compared
in control versus drug. The two-sample Kolmogorov-Smirnov (KS-2) test was
used to compare pooled cumulative frequency distributions of each compo-
nent in the absence versus the presence of quinpirole. Statistical significance
was set at p < 0.05 and was determined using the appropriate two-tailed
Student’s t test unless otherwise stated. Where it is stated that ANOVA was
used, a one-way ANOVA was performed with the Bonferroni test in post hoc
analysis. All data are presented as means ± SEM. Significance levels are indi-
cated as: * = p < 0.05; ** = p < 0.01; and *** = p < 0.001.
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